id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA_FRDOC_0001-0508,DEA,DEA_FRDOC_0001,Designation of Propionyl Chloride as a List I Chemical,Rule,,2026-03-10T04:00:00Z,2026,3,2026-03-10T04:00:00Z,,2026-03-10T16:55:22Z,2026-04657,0,0,09000064b9206be3
DEA_FRDOC_0001-0507,DEA,DEA_FRDOC_0001,"Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act",Rule,,2026-03-02T05:00:00Z,2026,3,2026-03-02T05:00:00Z,,2026-03-02T18:40:50Z,2026-04112,0,0,09000064b91e8fdf
DEA_FRDOC_0001-0506,DEA,DEA_FRDOC_0001,Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017,Rule,,2026-02-05T05:00:00Z,2026,2,2026-02-05T05:00:00Z,,2026-02-05T17:30:25Z,2026-02288,0,0,09000064b919298b
DEA-2023-0057-0003,DEA,DEA-2023-0057,Definition of Cannabimimetic Agents and Assignment of an Administration Controlled Substances Code Number for all Cannabimimetic Agents,Rule,,2026-01-20T05:00:00Z,2026,1,2026-01-20T05:00:00Z,,2026-01-20T23:44:45Z,2026-00907,0,0,09000064b9161314
DEA-2025-0075-0014,DEA,DEA-2025-0075,Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I,Rule,,2026-01-15T05:00:00Z,2026,1,2026-01-15T05:00:00Z,,2026-01-16T20:17:00Z,2026-00633,0,0,09000064b9152a07
DEA-2024-0118-0004,DEA,DEA-2024-0118,Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I,Rule,,2026-01-12T05:00:00Z,2026,1,2026-01-12T05:00:00Z,,2026-01-13T02:58:59Z,2026-00362,0,0,09000064b913658f
DEA-2023-0029-41937,DEA,DEA-2023-0029,Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications,Rule,,2025-12-31T05:00:00Z,2025,12,2025-12-31T05:00:00Z,,2026-01-13T03:01:01Z,2025-24123,0,0,09000064b9113f32
DEA-2023-0147-0004,DEA,DEA-2023-0147,Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I,Rule,,2025-12-23T05:00:00Z,2025,12,2025-12-23T05:00:00Z,,2026-01-06T01:10:17Z,2025-23717,0,0,09000064b91067de
DEA-2025-0918-0001,DEA,DEA-2025-0918,"Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act",Rule,,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,,2025-12-16T21:28:16Z,2025-22960,0,0,09000064b90da7df
DEA-2025-0555-0055,DEA,DEA-2025-0555,Schedules of Controlled Substances: Extension of Temporary Placement of MDMB-4en-PINACA in Schedule I,Rule,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,,2025-12-11T19:41:46Z,2025-22540,0,0,09000064b90c55b5
DEA-2025-0852-0002,DEA,DEA-2025-0852,Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I,Rule,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,,2025-12-11T19:46:09Z,2025-22496,0,0,09000064b90c55b7
DEA-2024-0144-0006,DEA,DEA-2024-0144,Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I,Rule,,2025-11-17T05:00:00Z,2025,11,2025-11-17T05:00:00Z,,2025-11-20T02:13:12Z,2025-20004,0,0,09000064b9085a3d
DEA-2025-0588-0001,DEA,DEA-2025-0588,"Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I",Rule,,2025-10-15T04:00:00Z,2025,10,2025-10-15T04:00:00Z,,2025-10-17T03:23:35Z,2025-19542,0,0,09000064b901aa49
DEA-2025-0558-0001,DEA,DEA-2025-0558,Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction,Rule,,2025-10-02T04:00:00Z,2025,10,2025-10-02T04:00:00Z,,2025-10-03T01:30:04Z,2025-19292,0,0,09000064b8ff064c
DEA-2023-0016-0010,DEA,DEA-2023-0016,Controlled Substances Ordering System Modernization,Rule,,2025-10-02T04:00:00Z,2025,10,2025-10-02T04:00:00Z,,2025-10-03T01:31:47Z,2025-19325,0,0,09000064b8ff074c
DEA-2025-0556-0001,DEA,DEA-2025-0556,"Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical",Rule,,2025-10-02T04:00:00Z,2025,10,2025-10-02T04:00:00Z,,2025-10-03T01:20:48Z,2025-19349,0,0,09000064b8ff07c5
DEA-2024-0148-0006,DEA,DEA-2024-0148,Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I,Rule,,2025-09-18T04:00:00Z,2025,9,2025-09-18T04:00:00Z,,2025-10-03T01:28:48Z,2025-18103,0,0,09000064b8fb0ed1
DEA-2024-0118-0003,DEA,DEA-2024-0118,Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I,Rule,,2025-08-15T04:00:00Z,2025,8,2025-08-15T04:00:00Z,,2025-08-15T17:55:48Z,2025-15566,0,0,09000064b8f008ec
DEA-2025-0192-0003,DEA,DEA-2025-0192,"Specific Listing for Dipentylone, A Currently Controlled Schedule I Substance",Rule,,2025-08-08T04:00:00Z,2025,8,2025-08-08T04:00:00Z,,2025-09-10T04:16:28Z,2025-15177,0,0,09000064b8ef0c9b
DEA-2022-0145-0005,DEA,DEA-2022-0145,"Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I",Rule,,2025-07-25T04:00:00Z,2025,7,2025-07-25T04:00:00Z,,2025-07-25T16:18:35Z,2025-14037,0,0,09000064b8e9cab5
DEA-2024-0026-0002,DEA,DEA-2024-0026,Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I; Correction,Rule,,2025-06-03T00:00:00Z,2025,6,2025-06-03T00:00:00Z,,2025-06-03T21:07:54Z,2025-09989,0,0,09000064b8dceccb
DEA-2023-0028-2951,DEA,DEA-2023-0028,Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients,Rule,,2025-03-24T04:00:00Z,2025,3,2025-03-24T04:00:00Z,,2025-06-03T00:09:09Z,2025-05007,0,0,0900006486a29032
DEA-2023-0028-2918,DEA,DEA-2023-0028,Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients,Rule,,2025-02-19T05:00:00Z,2025,2,2025-02-19T05:00:00Z,2025-03-01T04:59:59Z,2025-03-01T23:55:45Z,2025-02793,0,0,0900006486971375
DEA-2023-0028-2917,DEA,DEA-2023-0028,Expansion of Buprenorphine Treatment via Telemedicine Encounter,Rule,,2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-21T13:53:50Z,2025-01049,0,0,09000064868e2eb2
DEA-2023-0029-35464,DEA,DEA-2023-0029,Continuity of Care via Telemedicine for Veterans Affairs Patients,Rule,,2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-01-21T13:54:28Z,2025-01044,0,0,09000064868e2ffd
DEA-2024-0148-0001,DEA,DEA-2024-0148,Schedules of Controlled Substances: Extension of Temporary Placement of Seven Specific Fentanyl-Related Substances in Schedule I,Rule,,2024-12-30T05:00:00Z,2024,12,2024-12-30T05:00:00Z,,2024-12-30T17:26:55Z,2024-31130,0,0,09000064868950c5
DEA-2023-0029-35463,DEA,DEA-2023-0029,Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications,Rule,,2024-11-19T05:00:00Z,2024,11,2024-11-19T05:00:00Z,,2024-11-27T19:50:54Z,2024-27018,0,0,090000648682777c
DEA-2021-0031-0011,DEA,DEA-2021-0031,"Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I",Rule,,2024-10-25T04:00:00Z,2024,10,2024-10-25T04:00:00Z,,2024-10-25T18:56:31Z,2024-24635,0,0,09000064867e36b5
DEA-2023-0129-0013,DEA,DEA-2023-0129,Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I,Rule,,2024-10-22T04:00:00Z,2024,10,2024-10-22T04:00:00Z,,2024-10-24T14:27:34Z,2024-24083,0,0,09000064867dd715
DEA-2023-0149-0005,DEA,DEA-2023-0149,Schedules of Controlled Substances: Placement of Zuranolone in Schedule IV,Rule,,2024-08-14T04:00:00Z,2024,8,2024-08-14T04:00:00Z,,2024-09-03T22:47:05Z,2024-18087,0,0,0900006486643896
DEA-2023-0147-0003,DEA,DEA-2023-0147,Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I,Rule,,2024-07-29T04:00:00Z,2024,7,2024-07-29T04:00:00Z,,2024-09-03T22:44:11Z,2024-16391,0,0,090000648660a036
DEA-2021-0031-0006,DEA,DEA-2021-0031,"Schedules of Controlled Substances: Placement of Etodesnitazene, N-Pyrrolidino etonitazene, and Protonitazene in Schedule I",Rule,,2024-04-11T04:00:00Z,2024,4,2024-04-11T04:00:00Z,,2024-05-03T19:53:46Z,2024-07684,0,0,09000064864cd87a
DEA-2021-0031-0008,DEA,DEA-2021-0031,"Schedules of Controlled Substances: Extension of Temporary Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I of the Controlled Substances Act",Rule,,2024-04-11T04:00:00Z,2024,4,2024-04-11T04:00:00Z,,2024-05-03T19:54:53Z,2024-07689,0,0,09000064864cd9c1
DEA-2024-0026-0001,DEA,DEA-2024-0026,Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I,Rule,,2024-03-15T04:00:00Z,2024,3,2024-03-15T04:00:00Z,,2024-03-19T12:47:48Z,2024-05543,0,0,090000648647c8be
DEA-2024-0009-0001,DEA,DEA-2024-0009,Conforming Amendment Regarding the Veterinary Medicine Mobility Act of 2014,Rule,,2024-02-08T05:00:00Z,2024,2,2024-02-08T05:00:00Z,,2024-02-08T15:01:26Z,2024-02322,0,0,09000064863f3b32
DEA-2023-0169-0001,DEA,DEA-2023-0169,Specific Listing for Currently Controlled Schedule I Substances,Rule,,2023-12-13T05:00:00Z,2023,12,2023-12-13T05:00:00Z,,2023-12-13T13:32:21Z,2023-27292,0,0,09000064863313c0
DEA-2023-0049-0004,DEA,DEA-2023-0049,"Schedules of Controlled Substances: Temporary Placement of MDMB–4en–PINACA, 4F–MDMB–BUTICA, ADB–4en–PINACA, CUMYL–PEGACLONE, 5F–EDMB–PICA, and MMB–FUBICA into Schedule I",Rule,,2023-12-12T05:00:00Z,2023,12,2023-12-12T05:00:00Z,,2023-12-12T15:08:02Z,2023-27243,0,0,0900006486328332
DEA-2023-0058-0012,DEA,DEA-2023-0058,Schedules of Controlled Substances: Placement of Nine Specific Fentanyl-Related Substances in Schedule I,Rule,,2023-12-07T05:00:00Z,2023,12,2023-12-07T05:00:00Z,,2023-12-07T13:20:25Z,2023-26694,0,0,090000648630ac74
DEA-2023-0059-0002,DEA,DEA-2023-0059,Designation of Halides of 4-Anilinopiperidine as List I Chemicals,Rule,,2023-10-31T04:00:00Z,2023,10,2023-10-31T04:00:00Z,,2023-10-31T13:33:44Z,2023-23927,0,0,090000648619fb8c
DEA-2023-0149-0001,DEA,DEA-2023-0149,Schedules of Controlled Substances: Placement of Zuranolone in Schedule IV,Rule,,2023-10-31T04:00:00Z,2023,10,2023-10-31T04:00:00Z,2023-12-01T04:59:59Z,2023-11-16T02:00:24Z,2023-23982,0,0,090000648619fc3f
DEA-2023-0146-0001,DEA,DEA-2023-0146,Additions to Listing of Exempt Chemical Mixtures,Rule,,2023-10-23T04:00:00Z,2023,10,2023-10-23T04:00:00Z,2023-11-23T04:59:59Z,2023-10-24T00:51:02Z,2023-23315,0,0,090000648612376e
DEA-2023-0029-35462,DEA,DEA-2023-0029,Second Temporary Extension of COVID–19 Telemedicine Flexibilities for Prescription of Controlled Medications,Rule,,2023-10-10T04:00:00Z,2023,10,2023-10-10T04:00:00Z,,2023-10-11T12:17:00Z,2023-22406,0,0,0900006486098b08
DEA-2019-0013-0260,DEA,DEA-2019-0013,Management of Quotas for Controlled Substances and List I Chemicals,Rule,,2023-08-31T04:00:00Z,2023,8,2023-08-31T04:00:00Z,,2023-08-31T12:33:18Z,2023-18885,0,0,0900006485f1e8bc
DEA-2021-0031-0005,DEA,DEA-2021-0031,Schedules of Controlled Substances: Placement of Metonitazene in Schedule I,Rule,,2023-08-18T04:00:00Z,2023,8,2023-08-18T04:00:00Z,,2023-08-18T12:43:23Z,2023-17778,0,0,0900006485e84a8b
DEA-2023-0106-0001,DEA,DEA-2023-0106,Dispensing of Narcotic Drugs to Relieve Acute Withdrawal Symptoms of Opioid Use Disorder,Rule,,2023-08-08T04:00:00Z,2023,8,2023-08-08T04:00:00Z,,2023-08-18T12:40:11Z,2023-16892,0,0,0900006485dfb7fe
DEA-2023-0098-0001,DEA,DEA-2023-0098,Implementation of the Designer Anabolic Steroid Control Act,Rule,,2023-08-01T04:00:00Z,2023,8,2023-08-01T04:00:00Z,,2023-08-01T13:29:53Z,2023-15747,0,0,0900006485d9b704
DEA-2021-0026-0185,DEA,DEA-2021-0026,Initial Filling: Transfer of Electronic Prescriptions for Schedules II–V Controlled Substances between Pharmacies,Rule,,2023-07-27T04:00:00Z,2023,7,2023-07-27T04:00:00Z,,2023-07-27T21:35:24Z,2023-15847,0,0,0900006485d5e100
DEA-2022-0145-0004,DEA,DEA-2022-0145,"Schedules of Controlled Substances: Temporary Placement ofEtizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I",Rule,,2023-07-26T04:00:00Z,2023,7,2023-07-26T04:00:00Z,,2025-07-30T17:42:01Z,2023-15748,0,0,0900006485d4c9a5
DEA-2020-0035-0039,DEA,DEA-2020-0035,Partial Filling of Prescriptions for Schedule II Controlled Substances,Rule,,2023-07-21T04:00:00Z,2023,7,2023-07-21T04:00:00Z,,2023-07-21T12:48:18Z,2023-15508,0,0,0900006485cf8fba
DEA-2020-0038-0006,DEA,DEA-2020-0038,Schedules of Controlled Substances: Placement of Brorphine in Schedule I; Correction,Rule,,2023-07-19T04:00:00Z,2023,7,2023-07-19T04:00:00Z,,2023-07-19T15:15:05Z,2023-15249,0,0,0900006485cdb926
DEA-2020-0022-0024,DEA,DEA-2020-0022,Reporting Theft or Significant Loss of Controlled Substances,Rule,,2023-06-22T04:00:00Z,2023,6,2023-06-22T04:00:00Z,,2023-06-22T15:34:58Z,2023-13085,0,0,0900006485bb0971
DEA-2023-0029-35460,DEA,DEA-2023-0029,Temporary Extension of COVID–19 Telemedicine Flexibilities for Prescription of Controlled Medications,Rule,,2023-05-10T04:00:00Z,2023,5,2023-05-10T04:00:00Z,,2023-05-10T13:01:17Z,2023-09936,0,0,09000064859ed53c
DEA-2022-0102-0005,DEA,DEA-2022-0102,Designation of a List I Chemical: 4-Piperidone,Rule,,2023-04-12T04:00:00Z,2023,4,2023-04-12T04:00:00Z,,2023-04-12T12:28:23Z,2023-07538,0,0,090000648593437e
DEA-2023-0056-0001,DEA,DEA-2023-0056,"Specific Listing for Eutylone, a Currently Controlled Schedule I Substance",Rule,,2023-04-10T04:00:00Z,2023,4,2023-04-10T04:00:00Z,,2023-04-10T14:31:00Z,2023-07335,0,0,090000648591b81a
DEA-2020-0038-0005,DEA,DEA-2020-0038,Schedules of Controlled Substances: Placement of Brorphine in Schedule I,Rule,,2023-03-06T05:00:00Z,2023,3,2023-03-06T05:00:00Z,,2023-03-07T14:27:36Z,2023-04364,0,0,09000064857608c9
DEA-2022-0068-0003,DEA,DEA-2022-0068,Schedules of Controlled Substances: Removal of Fenfluramine from Control,Rule,,2022-12-23T05:00:00Z,2022,12,2022-12-23T05:00:00Z,,2022-12-23T13:05:30Z,2022-27400,0,0,0900006485550c29
DEA-2021-0013-0006,DEA,DEA-2021-0013,Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I,Rule,,2022-12-09T05:00:00Z,2022,12,2022-12-09T05:00:00Z,,2022-12-12T14:18:13Z,2022-26805,0,0,090000648552a6b4
DEA-2022-0137-0001,DEA,DEA-2022-0137,2023 Established APQ,Rule,,2022-12-02T05:00:00Z,2022,12,2022-12-02T05:00:00Z,,2022-12-02T14:49:04Z,,0,0,09000064855122e6
DEA-2020-0027-0007,DEA,DEA-2020-0027,"Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration; Correction",Rule,,2022-11-29T05:00:00Z,2022,11,2022-11-29T05:00:00Z,,2022-11-30T13:07:10Z,2022-25823,0,0,0900006485507c87
DEA-2021-0012-0004,DEA,DEA-2021-0012,Schedules of Controlled Substances: Placement of Mesocarb in Schedule I,Rule,,2022-11-22T05:00:00Z,2022,11,2022-11-22T05:00:00Z,,2022-11-22T13:27:04Z,2022-25219,0,0,09000064854fbb4f
DEA-2021-0025-0010,DEA,DEA-2021-0025,Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control,Rule,,2022-11-21T05:00:00Z,2022,11,2022-11-21T05:00:00Z,,2022-11-21T13:27:57Z,2022-25212,0,0,09000064854f8554
DEA-2020-0015-0013,DEA,DEA-2020-0015,Schedules of Controlled Substances: Placement of Zipeprol in Schedule I,Rule,,2022-11-21T05:00:00Z,2022,11,2022-11-21T05:00:00Z,,2022-11-21T13:29:53Z,2022-25206,0,0,09000064854f8125
DEA-2021-0011-0007,DEA,DEA-2021-0011,Schedules of Controlled Substances: Placement of Amineptine in Schedule I,Rule,,2022-11-17T05:00:00Z,2022,11,2022-11-17T05:00:00Z,,2022-11-17T13:05:24Z,2022-25003,0,0,09000064854bdf02
DEA-2020-0027-0006,DEA,DEA-2020-0027,"Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration",Rule,,2022-11-14T05:00:00Z,2022,11,2022-11-14T05:00:00Z,,2022-11-14T15:18:19Z,2022-24425,0,0,09000064854aab24
DEA-2022-0134-0001,DEA,DEA-2022-0134,"Specific Listing for 1-boc-4-AP, a Currently Controlled List I Chemical",Rule,,2022-11-09T05:00:00Z,2022,11,2022-11-09T05:00:00Z,,2022-11-09T16:35:58Z,2022-24155,0,0,090000648549d59a
DEA-2022-0051-0002,DEA,DEA-2022-0051,Schedules of Controlled Substances: Placement of Ganaxolone in Schedule V,Rule,,2022-11-09T05:00:00Z,2022,11,2022-11-09T05:00:00Z,,2022-11-09T16:24:54Z,2022-24157,0,0,090000648549cc67
DEA-2022-0133-0001,DEA,DEA-2022-0133,Regulation Regarding Registration Exception for Officials; Technical Correction,Rule,,2022-11-07T05:00:00Z,2022,11,2022-11-07T05:00:00Z,,2022-11-07T14:10:14Z,2022-24140,0,0,0900006485492c7f
DEA-2022-0025-0006,DEA,DEA-2022-0025,Schedules of Controlled Substances: Placement of Daridorexant in Schedule IV,Rule,,2022-09-30T04:00:00Z,2022,9,2022-09-30T04:00:00Z,,2022-09-30T12:20:37Z,2022-21253,0,0,0900006485389e23
DEA-2021-0010-0011,DEA,DEA-2021-0010,Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV,Rule,,2022-06-24T04:00:00Z,2022,6,2022-06-24T04:00:00Z,,2022-06-24T12:22:19Z,2022-13538,0,0,090000648518b8dd
DEA-2021-0030-0005,DEA,DEA-2021-0030,Schedules of Controlled Substances: Placement of Methoxetamine (MXE) in Schedule I,Rule,,2022-06-06T04:00:00Z,2022,6,2022-06-06T04:00:00Z,,2022-06-06T13:54:29Z,2022-11933,0,0,0900006485141202
DEA-2022-0050-0001,DEA,DEA-2022-0050,"Schedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4′-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4′-Chloro-alpha-pyrrolidinovalerophenone in Schedule I",Rule,,2022-06-01T04:00:00Z,2022,6,2022-06-01T04:00:00Z,,2022-06-01T16:54:35Z,2022-11740,0,0,090000648511e3a3
DEA-2022-0051-0001,DEA,DEA-2022-0051,Schedules of Controlled Substances: Placement of Ganaxolone in Schedule V,Rule,,2022-06-01T04:00:00Z,2022,6,2022-06-01T04:00:00Z,2022-07-02T03:59:59Z,2022-06-01T16:56:42Z,2022-11735,0,0,090000648511e3a9
DEA-2021-0031-0004,DEA,DEA-2021-0031,"Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-Pyrrolidino etonitazene, and Protonitazene in Schedule I",Rule,,2022-04-12T04:00:00Z,2022,4,2022-04-12T04:00:00Z,,2022-04-12T12:55:17Z,2022-07640,0,0,090000648500fd5c
DEA-2021-0005-0006,DEA,DEA-2021-0005,Requiring Online Submission of Applications for and Renewals of DEA Registration,Rule,,2022-04-11T04:00:00Z,2022,4,2022-04-11T04:00:00Z,,2022-04-11T12:29:28Z,2022-07570,0,0,090000648500abee
DEA-2019-0002-0010,DEA,DEA-2019-0002,"Schedules of Controlled Substances: Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I",Rule,,2022-04-07T04:00:00Z,2022,4,2022-04-07T04:00:00Z,,2022-04-07T15:06:01Z,2022-07320,0,0,0900006484fff3b7
DEA-2022-0025-0001,DEA,DEA-2022-0025,Schedules of Controlled Substances: Placement of Daridorexant in Schedule IV,Rule,,2022-04-07T04:00:00Z,2022,4,2022-04-07T04:00:00Z,2022-05-10T03:59:59Z,2022-05-03T13:22:43Z,2022-07322,0,0,0900006484fff3ba
DEA-2021-0009-0002,DEA,DEA-2021-0009,"Designation as a List I Chemical: Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine",Rule,,2021-11-18T05:00:00Z,2021,11,2021-11-18T05:00:00Z,,2021-11-18T17:15:49Z,2021-24952,0,0,0900006484e5f385
DEA-2020-0017-0005,DEA,DEA-2020-0017,Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I,Rule,,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,,2021-11-04T12:13:37Z,2021-23848,0,0,0900006484e17dd9
DEA-2021-0015-0001,DEA,DEA-2021-0015,Schedules of Controlled Substances: Placement of Lemborexant in Schedule IV,Rule,,2021-11-03T04:00:00Z,2021,11,2021-11-03T04:00:00Z,,2021-11-05T13:57:18Z,2021-04183,0,0,0900006484a5c6dd
DEA-2021-0024-0001,DEA,DEA-2021-0024,Addition of the United States Space Force as a Registration Waiver and Registration Fee Exempt Military Entity,Rule,,2021-09-17T04:00:00Z,2021,9,2021-09-17T04:00:00Z,,2021-11-01T15:11:02Z,2021-19984,0,0,0900006484d8c25b
DEA-2020-0009-0006,DEA,DEA-2020-0009,"Schedules of Controlled Substances: Placement of 4,4′-DMAR in Schedule I",Rule,,2021-08-12T04:00:00Z,2021,8,2021-08-12T04:00:00Z,,2021-08-17T15:00:09Z,2021-17052,0,0,0900006484c48d9a
DEA-2020-0036-0001,DEA,DEA-2020-0036,Clarification Regarding the Supplier's DEA Registration Number on the Single-Sheet DEA Form 222,Rule,,2021-07-20T04:00:00Z,2021,7,2021-07-20T04:00:00Z,2021-09-21T03:59:59Z,2021-08-19T01:00:36Z,2021-15323,0,0,0900006484c03531
DEA-2019-0009-0002,DEA,DEA-2019-0009,"Schedules of Controlled Substances: Extension of Temporary Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4′-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4′-Chloro-alpha-pyrrolidinovalerophenone in Schedule I of the Controlled Substances Act",Rule,,2021-07-16T04:00:00Z,2021,7,2021-07-16T04:00:00Z,,2021-10-29T17:47:11Z,2021-15113,0,0,0900006484bfbc0b
DEA-2020-0005-0116,DEA,DEA-2020-0005,Registration Requirements for Narcotic Treatment Programs with Mobile Components,Rule,,2021-06-28T04:00:00Z,2021,6,2021-06-28T04:00:00Z,,2021-07-28T19:03:18Z,2021-13519,0,0,0900006484bb969c
DEA-2021-0023-0001,DEA,DEA-2021-0023,Schedules of Controlled Substances: Placement of para-Methoxymethamphetamine (PMMA) in Schedule I,Rule,,2021-06-25T04:00:00Z,2021,6,2021-06-25T04:00:00Z,,2021-10-29T13:41:35Z,2021-13460,0,0,0900006484bb1b28
DEA-2021-0022-0001,DEA,DEA-2021-0022,"Schedules of Controlled Substances: Specific Listing for 4F-MDMB-BINACA, a Currently Controlled Schedule I Substance",Rule,,2021-06-22T04:00:00Z,2021,6,2021-06-22T04:00:00Z,,2021-10-29T13:38:43Z,2021-13040,0,0,0900006484b9eb92
DEA-2019-0004-0003,DEA,DEA-2019-0004,Schedules of Controlled Substances: Placement of N-Ethylpentylone in Schedule I,Rule,,2021-06-14T04:00:00Z,2021,6,2021-06-14T04:00:00Z,,2021-08-18T13:25:42Z,2021-12261,0,0,0900006484b7a208
DEA-2020-0032-0005,DEA,DEA-2020-0032,Schedules of Controlled Substances: Placement of Oliceridine in Schedule II,Rule,,2021-06-10T04:00:00Z,2021,6,2021-06-10T04:00:00Z,,2021-06-14T19:51:45Z,2021-11981,0,0,0900006484b63b03
DEA-2021-0021-0001,DEA,DEA-2021-0021,"Schedules of Controlled Substances: Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA, and 5F-CUMYL-P7AICA in Schedule I",Rule,,2021-06-10T04:00:00Z,2021,6,2021-06-10T04:00:00Z,,2021-10-29T13:35:32Z,2021-11974,0,0,0900006484b63b53
DEA-2021-0020-0002,DEA,DEA-2021-0020,"Designation of 3,4-MDP-2-P methyl glycidate (PMK glycidate), 3,4-MD-2-P methyl glycidic acid (PMK glycidic acid), and alpha-phenylacetoacetamide (APAA) as List I Chemicals: Correction",Rule,,2021-06-07T04:00:00Z,2021,6,2021-06-07T04:00:00Z,,2021-10-29T13:22:51Z,2021-11836,0,0,0900006484b59277
DEA-2020-0028-0007,DEA,DEA-2020-0028,Schedules of Controlled Substances: Placement of Remimazolam in Schedule IV,Rule,,2021-06-02T04:00:00Z,2021,6,2021-06-02T04:00:00Z,,2021-08-18T13:34:04Z,2021-11512,0,0,0900006484b4cd8d
DEA-2020-0003-0010,DEA,DEA-2020-0003,Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V,Rule,,2021-05-24T04:00:00Z,2021,5,2021-05-24T04:00:00Z,,2021-05-25T15:49:44Z,2021-10827,0,0,0900006484b2e413
DEA-2021-0020-0001,DEA,DEA-2021-0020,"Designation of 3,4-MDP-2-P methyl glycidate (PMK glycidate), 3,4-MDP-2-P methyl glycidicacid (PMK glycidic acid), and alpha-phenylacetoacetamide (APAA) as List I Chemicals",Rule,,2021-05-10T04:00:00Z,2021,5,2021-05-10T04:00:00Z,,2021-10-29T13:18:05Z,2021-09697,0,0,0900006484ae1df4
DEA-2021-0010-0001,DEA,DEA-2021-0010,Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV,Rule,,2021-05-07T04:00:00Z,2021,5,2021-05-07T04:00:00Z,2021-06-08T03:59:59Z,2021-06-03T01:00:21Z,2021-09738,0,0,0900006484ad863b
DEA-2021-0019-0001,DEA,DEA-2021-0019,Schedules of Controlled Substances: Placement of Four Specific Fentanyl-Related Substances in Schedule I,Rule,,2021-05-04T04:00:00Z,2021,5,2021-05-04T04:00:00Z,,2021-10-29T13:14:00Z,2021-09402,0,0,0900006484aca7bd
DEA-2021-0018-0001,DEA,DEA-2021-0018,Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances in Schedule I,Rule,,2021-04-27T04:00:00Z,2021,4,2021-04-27T04:00:00Z,,2021-10-29T13:09:29Z,2021-08720,0,0,0900006484ab8209
DEA-2021-0017-0001,DEA,DEA-2021-0017,Schedules of Controlled Substances: Removal of Samidorphan From Control,Rule,,2021-04-19T04:00:00Z,2021,4,2021-04-19T04:00:00Z,,2021-10-29T11:35:21Z,2021-07884,0,0,0900006484aab9de
DEA-2019-0002-0009,DEA,DEA-2019-0002,"Schedules of Controlled Substances: Extension of Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA and FUB-144 in Schedule I of the Controlled Substances Act",Rule,,2021-03-31T04:00:00Z,2021,3,2021-03-31T04:00:00Z,,2021-05-17T13:12:19Z,2021-06555,0,0,0900006484a91bd6
DEA-2021-0016-0001,DEA,DEA-2021-0016,"Schedules of Controlled Substances: Placement of cyclopentyl fentanyl, isobutyryl fentanyl, para-chloroisobutyryl fentanyl, para-methoxybutyryl fentanyl, and valeryl fentanyl in Schedule I; Correction",Rule,,2021-03-31T04:00:00Z,2021,3,2021-03-31T04:00:00Z,,2021-10-28T17:54:17Z,2021-06596,0,0,0900006484a91c1f
DEA-2020-0038-0004,DEA,DEA-2020-0038,Schedules of Controlled Substances: Temporary Placement of Brorphine in Schedule I,Rule,,2021-03-01T05:00:00Z,2021,3,2021-03-01T05:00:00Z,,2023-03-02T13:25:25Z,2021-04242,0,0,0900006484a5717c